US FDA approves Eton Pharma's hormonal disorder drug
25/02/2026 18:48
Feb 25 (Reuters) - The U.S. Food and Drug Administration approved on Wednesday Eton Pharmaceuticals' ETON.O oral liquid therapy for a rare childhood hormonal disorder, giving families an easier way to manage the condition and keep children hydrated. (Reporting by Kamal Choudhury in Bengaluru; Editing by Alan Barona) ((Kamal.Choudhury@thomsonreuters.com))
Recent news on Eton Pharmaceuticals
See all newsBrief: Eton Pharmaceuticals Under Agreement, Co Pays Aquestive Upfront License Fee Of $10 Million - SEC Filing
Aquestive rises on US licensing deal for seizure drug with Eton Pharma
U.S. STOCKS ON THE MOVE-Sun Communities, Cisco Systems, Paysafe
U.S. STOCKS ON THE MOVE-Fox, Sun Communities, Reddit, drone firms
U.S. STOCKS ON THE MOVE-Boost Run, Nektar Therapeutics, Swarmer